The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors (Q42450601)

31 October 2017

The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors (English)

1 reference

31 October 2017

Orenstein A

1

1 reference

31 October 2017

Kostenich G

series ordinal

2

1 reference

31 October 2017

Malik Z

series ordinal

3

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

31 October 2017

1 reference

31 October 2017

120

1 reference

31 October 2017

2

1 reference

31 October 2017

229-234

1 reference

Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Porphyrins, porphyrias, cancer and photodynamic therapy--a model for carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Photosensitizers: therapy and detection of malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

5-aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced friend erythroleukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Destruction of erythroleukemia, myelocytic leukemia and Burkitt lymphoma cells by photoactivated protoporphyrin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Photobleaching of porphyrins used in photodynamic therapy and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Effect of bleaching of porphyrin sensitizers during photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Quantum yields and kinetics of the photobleaching of hematoporphyrin, Photofrin II, tetra(4-sulfonatophenyl)-porphine and uroporphyrin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2897%2900315-7

7 January 2021

10.1016/S0304-3835(97)00315-7

Identifiers

DOI

1 reference

31 October 2017

1 reference